BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12800154)

  • 1. More extensive genetic alterations in unmutated than in hypermutated cases of chronic lymphocytic leukemia.
    Karhu R; Tobin G; Thunberg U; Vilpo L; Sundström C; Knuutila S; Rosenquist R; Vilpo J
    Genes Chromosomes Cancer; 2003 Aug; 37(4):417-20. PubMed ID: 12800154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course.
    Stilgenbauer S; Bullinger L; Lichter P; Döhner H;
    Leukemia; 2002 Jun; 16(6):993-1007. PubMed ID: 12040431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic transplant with reduced intensity conditioning regimens may overcome the poor prognosis of B-cell chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene and chromosomal abnormalities (11q- and 17p-).
    Caballero D; García-Marco JA; Martino R; Mateos V; Ribera JM; Sarrá J; León A; Sanz G; de la Serna J; Cabrera R; González M; Sierra J; San Miguel J
    Clin Cancer Res; 2005 Nov; 11(21):7757-63. PubMed ID: 16278397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of different chromosomal aberrations on molecular cytogenetic parameters in chronic lymphocytic leukemia.
    Amiel A; Leopold L; Gronich N; Yukla M; Fejgin MD; Lishner M
    Cancer Genet Cytogenet; 2006 Jun; 167(2):145-9. PubMed ID: 16737914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitogen induced activation, proliferation and surface antigen expression patterns in unmutated and hypermutated chronic lymphocytic leukemia cells.
    Vilpo J; Tobin G; Hulkkonen J; Hurme M; Thunberg U; Sundström C; Vilpo L; Rosenquist R
    Eur J Haematol; 2005 Jul; 75(1):34-40. PubMed ID: 15946308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia.
    Bentz M; Plesch A; Bullinger L; Stilgenbauer S; Ott G; Müller-Hermelink HK; Baudis M; Barth TF; Möller P; Lichter P; Döhner H
    Genes Chromosomes Cancer; 2000 Mar; 27(3):285-94. PubMed ID: 10679918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of chromosomal anomalies detected with FISH and their clinical correlations in B-chronic lymphocytic leukemia.
    Sindelárová L; Michalová K; Zemanová Z; Ransdorfová S; Brezinová J; Peková S; Schwarz J; Karban J; Cmunt E
    Cancer Genet Cytogenet; 2005 Jul; 160(1):27-34. PubMed ID: 15949567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgVH gene mutation status and genomic imbalances in chronic lymphocytic leukaemia with increased prolymphocytes (CLL/PL).
    Balogh Z; Reiniger L; Deák L; Bödör C; Csomor J; Szepesi A; Gagyi E; Kopper L; Matolcsy A
    Hematol Oncol; 2007 Jun; 25(2):90-5. PubMed ID: 17410523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic relevance of the FAB morphological criteria in chronic lymphocytic leukemia: correlations with IgVH gene mutational status and other prognostic markers.
    Schwarz J; Mikulenková D; Cermáková M; Polanská V; Michalová K; Marinov I; Campr V; Ransdorfová S; Marková J; Pavlistová L; Brezinová J; Sajdová J; Sponerová D; Volková Z; Benesová K; Cermák J; Vítek A; Cetkovský P
    Neoplasma; 2006; 53(3):219-25. PubMed ID: 16652191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Karyotype complexity and VH gene status in B-cell chronic lymphocytic leukemia.
    Méhes G; Kovács G; Kajtár B; Lacza A; Várnai A; Losonczy H; Pajor L
    Haematologica; 2006 Oct; 91(10):1430-1. PubMed ID: 16963400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique gene expression and clinical characteristics are associated with the 11q23 deletion in chronic lymphocytic leukaemia.
    Dickinson JD; Smith LM; Sanger WG; Zhou G; Townley P; Lynch JC; Pavletic ZS; Bierman PJ; Joshi SS
    Br J Haematol; 2005 Feb; 128(4):460-71. PubMed ID: 15686453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial B-cell chronic lymphocytic leukemia: analysis of cytogenetic abnormalities, immunophenotypic profiles, and immunoglobulin heavy chain gene usage.
    Aoun P; Zhou G; Chan WC; Page C; Neth K; Pickering D; Sanger W; Quinn-Laquer B; Watson P; Lynch JF; Lynch HT; Weisenburger DD
    Am J Clin Pathol; 2007 Jan; 127(1):31-8. PubMed ID: 17145621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70).
    Schade U; Bock O; Vornhusen S; Jäger A; Büsche G; Lehmann U; Kreipe H
    Hum Pathol; 2006 Sep; 37(9):1153-61. PubMed ID: 16938520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The origin of B-cell chronic lymphocytic leukemia.
    Ghia P; Caligaris-Cappio F
    Semin Oncol; 2006 Apr; 33(2):150-6. PubMed ID: 16616061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VH gene mutation status and cellular drug resistance in chronic lymphocytic leukaemia.
    Aleskog A; Tobin G; Laurell A; Thunberg U; Lindhagen E; Roos G; Nilsson K; Nygren P; Sundström C; Höglund M; Larsson R; Rosenquist R
    Eur J Haematol; 2004 Dec; 73(6):407-11. PubMed ID: 15522062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia.
    Kröber A; Seiler T; Benner A; Bullinger L; Brückle E; Lichter P; Döhner H; Stilgenbauer S
    Blood; 2002 Aug; 100(4):1410-6. PubMed ID: 12149225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and functional features of the B-cell receptor in IgG-positive chronic lymphocytic leukemia.
    Potter KN; Mockridge CI; Neville L; Wheatley I; Schenk M; Orchard J; Duncombe AS; Packham G; Stevenson FK
    Clin Cancer Res; 2006 Mar; 12(6):1672-9. PubMed ID: 16551848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes.
    Kienle DL; Korz C; Hosch B; Benner A; Mertens D; Habermann A; Kröber A; Jäger U; Lichter P; Döhner H; Stilgenbauer S
    J Clin Oncol; 2005 Jun; 23(16):3780-92. PubMed ID: 15867199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of IgV gene mutations in B cell chronic lymphocytic leukaemia according to antigen-driven selection identifies subgroups with different prognosis and usage of the canonical somatic hypermutation machinery.
    Degan M; Bomben R; Bo MD; Zucchetto A; Nanni P; Rupolo M; Steffan A; Attadia V; Ballerini PF; Damiani D; Pucillo C; Poeta GD; Colombatti A; Gattei V
    Br J Haematol; 2004 Jul; 126(1):29-42. PubMed ID: 15198729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic abnormalities in chronic lymphocytic leukemia influence gene expression by a gene dosage effect.
    Dickinson JD; Joshi A; Iqbal J; Sanger W; Bierman PJ; Joshi SS
    Int J Mol Med; 2006 May; 17(5):769-78. PubMed ID: 16596259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.